1. Home
  2. MPLT vs UAN Comparison

MPLT vs UAN Comparison

Compare MPLT & UAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$11.75

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo CVR Partners LP

UAN

CVR Partners LP

HOLD

Current Price

$123.80

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPLT
UAN
Founded
2018
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.3B
IPO Year
2025
2008

Fundamental Metrics

Financial Performance
Metric
MPLT
UAN
Price
$11.75
$123.80
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$32.67
N/A
AVG Volume (30 Days)
1.3M
30.1K
Earning Date
05-28-2026
04-29-2026
Dividend Yield
N/A
7.91%
EPS Growth
82.39
61.98
EPS
N/A
12.06
Revenue
N/A
$606,038,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$9.85
Revenue Growth
N/A
15.36
52 Week Low
$9.10
$86.43
52 Week High
$40.43
$139.50

Technical Indicators

Market Signals
Indicator
MPLT
UAN
Relative Strength Index (RSI) 28.18 51.79
Support Level $9.10 $119.83
Resistance Level $20.73 $139.42
Average True Range (ATR) 1.49 3.39
MACD -0.16 -0.79
Stochastic Oscillator 35.72 45.77

Price Performance

Historical Comparison
MPLT
UAN

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

About UAN CVR Partners LP

CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.

Share on Social Networks: